Details for New Drug Application (NDA): 214528
✉ Email this page to a colleague
The generic ingredient in EPHEDRINE SULFATE is ephedrine sulfate. There are sixty-eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.
Summary for 214528
Tradename: | EPHEDRINE SULFATE |
Applicant: | Sagent Pharms Inc |
Ingredient: | ephedrine sulfate |
Patents: | 0 |
Pharmacology for NDA: 214528
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Increased Norepinephrine Activity |
Medical Subject Heading (MeSH) Categories for 214528
Suppliers and Packaging for NDA: 214528
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EPHEDRINE SULFATE | ephedrine sulfate | SOLUTION;INTRAVENOUS | 214528 | ANDA | Sagent Pharmaceuticals | 25021-836 | 25021-836-01 | 25 VIAL in 1 CARTON (25021-836-01) / 1 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/ML (50MG/ML) | ||||
Approval Date: | Mar 9, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription